Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 +0.00 (+0.00%)
As of: Oct 2, 2026 · 3:21 PM EDT

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024)

Updated

Abvc Biopharma's Short-Term Debt issuances was $30,000 in FY2024.

Analysis

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024) Analysis & Trends

From FY2018 onward, Abvc Biopharma has reported Short-Term Debt issuances for 5 years.

  • Short-Term Debt issuances shows a five-year compound annual growth rate of -50.4% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Short-Term Debt issuances in data going back to FY2018.
  • Per Business Quant data, Short-Term Debt issuances in earlier years was $350,000 in FY2022 and $100,000 in FY2020 (-90.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 707.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Abvc Biopharma 27.31 Mn 29.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 30,000.00
Dec 31, 2020 -412,212.00
Sep 30, 2020 480,362.00
Jun 30, 2020 -249,090.00
Mar 31, 2020 280,940.00
Dec 31, 2019 153,700.00
Dec 31, 2018 49,008.00
Sep 30, 2018 75,990.00
Jun 30, 2018 -256,550.00
Mar 31, 2018 312,824.00
API Access

Abvc Biopharma Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=ABVC&period=max&api_key=YOUR_API_KEY